• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Long-term postoperative courses of hepatocellular carcinoma with and without cirrhosis].

作者信息

Sasaki Y, Imaoka S, Masutani S, Nagano H, Ohashi I, Kameyama M, Ohigashi H, Hiratsuka M, Ishikawa O, Kabuto T

机构信息

Dept. of Surgery, Center for Adult Diseases, Osaka.

出版信息

Gan To Kagaku Ryoho. 1990 Mar;17(3 Pt 2):435-9.

PMID:2157365
Abstract

Until the end of August 1988, 158 patients with hepatocellular carcinoma underwent curative hepatic resection in our department. One-hundred and twenty-one patients (77%) had liver cirrhosis (Group A), and the remaining 37 (23%) did not (Group B). Background factors and postoperative courses were compared between Group A and Group B. With regard to clinical stage and curability, there were no significant differences between the two groups. On postoperative follow-up on 1- to 5-year survival, no differences were recognized between the two groups, but on and after 6-year survival, the former were significantly worse than the latter. The main cause of death was cancer in both groups. In group B, all intrahepatic recurrences happened within 3 years after surgery. On the other hand, intrahepatic recurrences of Group A were also found on postoperative 4- and 5-year to be as numerous as the recurrences found at 1-, 2- and 3-year after surgery. Moreover, with recurrent cases on and after 4 years in Group A, the frequency of solitary focus was high. The differences of postoperative courses between these two groups might be caused by metachronous carcinogenesis of cirrhotic liver.

摘要

相似文献

1
[Long-term postoperative courses of hepatocellular carcinoma with and without cirrhosis].
Gan To Kagaku Ryoho. 1990 Mar;17(3 Pt 2):435-9.
2
Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.对合并肝硬化的肝细胞癌进行肝切除。
Hepatogastroenterology. 2002 Sep-Oct;49(47):1363-8.
3
Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.丙型肝炎病毒相关肝硬化患者肝细胞癌切除术后应用辅助性碘(131)标记碘化油预防肝内复发
Eur J Surg Oncol. 2007 Feb;33(1):61-6. doi: 10.1016/j.ejso.2006.10.039. Epub 2006 Dec 18.
4
Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.非肝硬化性肝脏来源的肝细胞癌肝切除的长期结果
Arch Surg. 2004 Mar;139(3):320-5; discussion 326. doi: 10.1001/archsurg.139.3.320.
5
Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.伴有肝硬化作为孤立性肝细胞癌切除术后复发的一个危险因素。
Hepatogastroenterology. 2003 Nov-Dec;50(54):1991-5.
6
[Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism].联合肝切除术和脾切除术在肝细胞癌合并肝硬化及脾功能亢进外科治疗中的作用
Zhonghua Wai Ke Za Zhi. 2005 Apr 1;43(7):442-6.
7
Hepatic function immediately after hepatectomy as a significant risk factor for early recurrence in hepatocellular carcinoma.肝切除术后的肝功能作为肝细胞癌早期复发的一个重要危险因素。
Hepatogastroenterology. 1999 Nov-Dec;46(30):3201-7.
8
Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.乙型肝炎病毒肝硬化相关孤立性肝细胞癌切除术后的辅助性肝化疗
Hepatobiliary Pancreat Dis Int. 2006 May;5(2):224-7.
9
[Hepatic resection for hepatocarcinoma in the cirrhotic patient].[肝硬化患者肝癌的肝切除术]
Chir Ital. 1999 Sep-Oct;51(5):345-54.
10
Results of repeated hepatectomy for recurrent hepatocellular carcinoma.
Hepatogastroenterology. 2007 Apr-May;54(75):858-61.